Literature DB >> 1977072

G to A substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI and high density lipoprotein cholesterol concentrations.

M Jeenah1, A Kessling, N Miller, S Humphries.   

Abstract

We have determined the sequence of 250 bases 5' of the transcriptional start site of the apolipoprotein AI gene in a human individual with high serum concentrations of apo AI. One of the alleles contained a G to A substitution at position -75, between the CACAT sequence and the TAAATA box, creating a tandem repeat, CAGGGC-CA*GGGC. The substitution destroys an MspI cutting site, and the polymerase chain reaction and MspI digestion were used to identify the presence of the A or G base. The frequency of the A substitution in 96 healthy men from Bristol was 0.11 and this was increased to 0.25 in men with serum apo AI concentrations greater than 180 mg/dl. Men with the A allele had significantly higher serum concentrations of apo AI, high density lipoprotein (HDL) cholesterol and HDL2 than those with the G allele. In this sample, variation associated with the G to A substitution accounted for 6% and 4.6% of the total variance in apo AI and HDL cholesterol concentrations, respectively. Although there is as yet no functional proof, it is possible that the A substitution may be having a direct positive effect on the rate of apo AI gene transcription and thus be associated with increased apo AI and HDL cholesterol concentrations because of increased production of apo AI protein from the liver or intestine.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977072

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  28 in total

Review 1.  Genetic causes of high and low serum HDL-cholesterol.

Authors:  Daphna Weissglas-Volkov; Päivi Pajukanta
Journal:  J Lipid Res       Date:  2010-04-26       Impact factor: 5.922

2.  An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in Japanese.

Authors:  Keisuke Shioji; Toshifumi Mannami; Yoshihiro Kokubo; Yoichi Goto; Hiroshi Nonogi; Naoharu Iwai
Journal:  J Hum Genet       Date:  2004-07-17       Impact factor: 3.172

3.  Can novel Apo A-I polymorphisms be responsible for low HDL in South Asian immigrants?

Authors:  Sunita Dodani; Yanbin Dong; Haidong Zhu; Varghese George
Journal:  Indian J Hum Genet       Date:  2008-01

4.  Contribution of polymorphisms in the apolipoprotein AI-CIII-AIV cluster to hyperlipidaemia in patients with gout.

Authors:  F Cardona; F J Tinahones; E Collantes; A Escudero; E García-Fuentes; F J Soriguer
Journal:  Ann Rheum Dis       Date:  2004-04-28       Impact factor: 19.103

5.  High density lipoprotein deficiency with xanthomas. A defect in reverse cholesterol transport caused by a point mutation in the apolipoprotein A-I gene.

Authors:  K J Lackner; H Dieplinger; G Nowicka; G Schmitz
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

6.  Linkage disequilibrium of three polymorphic RFLP markers in the apolipoprotein AI-CIII gene cluster on chromosome 11.

Authors:  O Marasco; F Melina; E Mele; B Quaresima; A Zingone; E Focarelli; E Picciotti; M L Martelli; L Fotino; M F Vigna
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

7.  HNF-4 increases activity of the rat Apo A1 gene.

Authors:  J Chan; H Nakabayashi; N C Wong
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

8.  Apolipoprotein A1 gene polymorphisms as risk factors for hypertension and obesity.

Authors:  Elizabeth Suchi Chen; Diego Robles Mazzotti; Tatiane Katsue Furuya; Maysa Seabra Cendoroglo; Luiz Roberto Ramos; Lara Quirino Araujo; Rommel Rodriguez Burbano; Marília de Arruda Cardoso Smith
Journal:  Clin Exp Med       Date:  2009-05-01       Impact factor: 3.984

9.  Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.

Authors:  Humaira Rasheed; Amanda J Phipps-Green; Ruth Topless; Malcolm D Smith; Catherine Hill; Susan Lester; Maureen Rischmueller; Matthijs Janssen; Timothy L Jansen; Leo A Joosten; Timothy R Radstake; Philip L Riches; Anne-Kathrin Tausche; Frederic Lioté; Alexander So; Andre van Rij; Gregory T Jones; Sally P McCormick; Andrew A Harrison; Lisa K Stamp; Nicola Dalbeth; Tony R Merriman
Journal:  Rheumatology (Oxford)       Date:  2016-04-18       Impact factor: 7.580

10.  Evaluation of G-to-A substitution in the apolipoprotein A-I gene promoter as a determinant of high-density lipoprotein cholesterol level in subjects with and without cholesteryl ester transfer protein deficiency.

Authors:  H Akita; H Chiba; M Tsuji; S P Hui; Y Takahashi; K Matsuno; K Kobayashi
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.